EXEL - Exelixis drops quickly on day four of Cabometyx patent trial May, 19 2022 12:08 PM Exelixis Inc. Exelixis (NASDAQ:EXEL) plunged 14% during day four of the Cabometyx patent trial. Developing story ... For further details see: Exelixis drops quickly on day four of Cabometyx patent trial